Drug Research
Eisai: Antiepileptic Drug Fycompa Regularly Available Again in Germany from December
Eisai Co., Ltd. has announced that its German sales company Eisai GmbH and the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) have agreed...
News
leon-nanodrugs Congratulates its Partner MJR Pharmjet on Receiving Prestigious CPhI Award 2017 for Highly Innovative MicroJet Reactor Technology
The CPhI Pharma Awards are among the most prestigious recognitions within the pharmaceutical industry. MJR PharmJet, partner of leon-nanodrugs GmbH in drug development received...
Press Releases
Quanticate launches statistical monitoring services following the ICH GCP E6(R2) addendum
Quanticate, a data-focused clinical research organisation (CRO), has launched its centralised statistical monitoring service (https://www.quanticate.com/centralized-statistical-monitoring) as an extension of its statistical consultancy offering in...
Press Releases
Successful First-in-Human Testing of Implandata’s Next Generation EYEMATE™ Micro-Sensor for Improved Monitoring of Glaucoma Patients
Implandata Ophthalmic Products GmbH (Implandata) is a privately held, ISO 13485 certified medical device company founded in 2010 in Hannover/Germany. Implandata’s...
News
The ‘India Pharma Week’ returns with a week full of avant-garde events alongside CPhI and P-MEC India
UBM India, India's leading B2B exhibition organizer, is all set to bring in the second edition of the widely appreciated India Pharma Week, a...
News
Drug Development: Making the impossible possible
THE Advancing Drug Development Forum has confirmed a prestigious line-up of leading industry voices to speak at its inaugural event. Taking...
News
Oxford Genetics licenses SnapFast™ expression vectors to Twist Bioscience
Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced a new licensing agreement with Twist Bioscience Corporation....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read















